查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2016609

转染技术市场规模、份额、趋势和预测：按产品类型、应用、转染方法、技术、最终用户和地区划分，2026-2034年

Transfection Technologies Market Size, Share, Trends and Forecast by Product Type, Application, Transfection Method, Technology, End-User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

2025年全球转染技术市场规模为13.486亿美元。展望未来，IMARC集团预测，该市场将以6.56%的复合年增长率从2026年增长至2034年，到2034年达到24.313亿美元。目前，北美市场主导地位，2025年市占率达39.3%。转染技术市场份额的成长得益于强大的研究基础设施、高额的医疗保健支出、先进基因组分析工具的广泛应用、生物技术和製药公司的强大实力，以及政府对基因研究和药物研发的支持。

转染技术是指将核酸（例如去氧核糖核酸(DNA)、核糖核酸 (RNA) 和寡核苷酸）人工导入细胞的过程。该技术可透过多种物理、化学和生物学方法实现，并可用于改变细胞的特定性质。其方法包括共转染、电穿孔、阳离子脂质体转染及体内转染等。此技术广泛应用于各种基因组学研究，例如基因表现、筛检、 RNA干扰和体内研究，以及病毒和蛋白质的生物生产。

癌症和各种文明病的日益普及是推动市场成长的主要因素之一。此外，基于试剂的方法的普及也促进了市场成长。与传统技术相比，基于试剂的转染操作更简单、成本更低。因此，诸如生物切割技术、显微注射和雷射转染等方法正受到全球的广泛关注。细胞研究和治疗方法发现领域的各种技术进步是推动市场成长的另一个主要因素。因此，基因转殖研究主要在体内条件下进行，旨在开发新的治疗药物和其他应用。此外，政府和私营机构增加对大规模转染设施建设的投资，以及在蛋白质疗法领域进行广泛的研发活动，预计也将进一步推动市场扩张。

市场区隔

本报告分析了全球转染技术市场各细分领域的关键趋势，并提供了 2026 年至 2034 年的全球、区域和国家特定预测。该报告根据产品类型、应用、转染方法、技术和最终用户对市场进行了细分。

按产品类型细分

  • 试剂
  • 装置
  • 其他的

按用途细分

  • 药物输送
  • 生物医学研究
  • 蛋白质生产
  • 其他的

依转染方法分类

  • 脂质体
  • 电穿孔
  • 核转染
  • 共转染
  • 阳离子脂质转染
  • 体内转染
  • 其他的

依技术分类

  • 物理转染
  • 生化转染
  • 利用病毒载体进行转染

按最终用户分类

  • 研究中心和学术机构
  • 医院和诊所
  • 製药和生物技术公司
  • 其他的

按地区划分

  • 北美洲
  • 我们
  • 加拿大
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 印尼
  • 其他的
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他的
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他的
  • 中东和非洲

竞争格局

该报告还分析了市场的竞争格局，主要企业介绍了安捷伦科技、Bio-Rad Laboratories、Lonza Group AG、MaxSight、Myras Bio LLC、Polyplus Transfections、Promega Corporation、罗氏控股、Sigma-Aldrich 和赛默飞世尔科技等主要参与者。

本报告解答的主要问题

1. 到 2025 年，全球转染技术市场规模将达到多少？

2. 2026 年至 2034 年全球转染技术市场的预期成长率为何？

3. 推动全球转染技术市场发展的主要因素是什么？

4. COVID-19 对全球转染技术市场产生了哪些影响？

5. 全球转染技术市场依产品类型分類的组成是什么？

6. 全球转染技术市场按应用领域分類的组成是什么？

7. 全球转染技术市场依转染方法分類的组成是什么？

8. 全球转染技术市场依技术分類的组成是什么？

9. 全球转染技术市场的主要区域有哪些？

10. 全球转染技术市场的主要参与者/公司有哪些？

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 二手资讯
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球转染技术市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依产品类型划分

  • 试剂
  • 装置
  • 其他的

第七章 市场区隔：依应用领域划分

  • 药物输送
  • 生物医学研究
  • 蛋白质生产
  • 其他的

第八章 市场区隔：依转染法划分

  • 脂质体
  • 电穿孔
  • 核转染
  • 共转染
  • 阳离子脂质转染
  • 体内转染
  • 其他的

第九章 市场区隔：依技术划分

  • 物理转染
  • 生化转染
  • 利用病毒载体进行转染

第十章 市场区隔：依最终用户划分

  • 研究机构和学术机构
  • 医院和诊所
  • 製药和生物技术公司
  • 其他的

第十一章 市场区隔：按地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十二章 SWOT 分析

第十三章：价值链分析

第十四章：波特五力分析

第十五章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Agilent Technologies Inc.
    • Altogen Biosystems
    • Amsbio
    • Bio-RAD Laboratories Inc.
    • Lonza Group AG
    • Maxcyte Inc.
    • Mirus Bio LLC
    • Promega Corporation
    • QIAGEN NV
    • Sartorius AG
    • SignaGen Laboratories
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A2188

The global transfection technologies market size was valued at USD 1,348.6 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 2,431.3 Million by 2034, exhibiting a CAGR of 6.56% from 2026-2034. North America currently dominates the market, holding a market share of 39.3% in 2025. The transfection technologies market share is growing because of strong research infrastructure, high healthcare spending, widespread adoption of advanced genomic tools, significant biotech and pharma presence, and supportive government funding for genetic research and drug discovery.

Transfection technology refers to the process of artificially introducing nucleic acid, such as Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA) and oligonucleotides, into the cells. It is introduced using various physical, chemical and biological methods, which can assist in modifying certain properties of the cell. It involves various methods, including cotransfection, electroporation, cationic lipid transfection and in-vivo transfection. This process is commonly used for various genomic studies that include gene expression, screening, RNA interference and Vivo research, along with the bioproduction of viruses and proteins.

The increasing prevalence of cancer and various chronic lifestyle diseases is one of the key factors driving the growth of the market. Furthermore, widespread adoption of reagent-based methods is also providing a boost to the market growth. In comparison to the traditionally used techniques, reagent-based transfection is less complicated to administer and more cost-effective. In line with this, instrument-based methods, such as biolistic technology, microinjection and laserfection, are also gaining immense traction across the globe. Various technological advancements in cell research and therapeutic discovery are acting as another major growth-inducing factor. In line with this, research in gene transfer is majorly performed under in-vivo conditions for the development of novel therapeutic drugs and various other applications. Other factors, including increasing investments by both government and private organizations to develop large scale transfection facilities, along with extensive research and development (R&D) activities in the field of protein therapeutics, are projected to drive the market further.

Market Segmentation

This report provides an analysis of the key trends in each sub-segment of the global transfection technologies market report, along with forecasts at the global, regional and country level from 2026-2034. The report has categorized the market based on product type, application, transfection method, technology and end-user.

Breakup by Product Type

  • Reagent
  • Instrument
  • Others

Breakup by Application

  • Therapeutic Delivery
  • Bio-Medical Research
  • Protein Production
  • Others

Breakup by Transfection Method

  • Lipofection
  • Eletroporation
  • Nucleofection
  • Cotransfection
  • Cationic Lipid Transfection
  • In-Vivo Transfection
  • Others

Breakup by Technology

  • Physical Transfection
  • Biochemical Based Transfection
  • Viral-Vector Based Transfection

Breakup by End-User

  • Research Centers and Academic Institutes
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Breakup by Region

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Lonza Group AG, Maxcyte Inc., Mirus Bio LLC, Polyplus Transfection, Promega Corporation, Roche Holding AG, Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report

1. What was the size of the global transfection technologies market in 2025?

2. What is the expected growth rate of the global transfection technologies market during 2026-2034?

3. What are the key factors driving the global transfection technologies market?

4. What has been the impact of COVID-19 on the global transfection technologies market?

5. What is the breakup of the global transfection technologies market based on the product type?

6. What is the breakup of the global transfection technologies market based on the application?

7. What is the breakup of the global transfection technologies market based on the transfection method?

8. What is the breakup of the global transfection technologies market based on the technology?

9. What are the key regions in the global transfection technologies market?

10. Who are the key players/companies in the global transfection technologies market?10. Who are the key players/companies in the global transfection technologies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transfection Technologies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Reagent
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instrument
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Therapeutic Delivery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bio-Medical Research
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Protein Production
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Transfection Method

  • 8.1 Lipofection
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Eletroporation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Nucleofection
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cotransfection
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Cationic Lipid Transfection
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 In-Vivo Transfection
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Technology

  • 9.1 Physical Transfection
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Biochemical Based Transfection
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Viral-Vector Based Transfection
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Research Centers and Academic Institutes
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals and Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Pharmaceutical and Biotechnology Companies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Altogen Biosystems
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Amsbio
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Bio-RAD Laboratories Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Lonza Group AG
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Maxcyte Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Mirus Bio LLC
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Promega Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 QIAGEN N.V.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sartorius AG
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 SignaGen Laboratories
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Takara Bio Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Thermo Fisher Scientific Inc.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Transfection Technologies Market: Major Drivers and Challenges
  • Figure 2: Global: Transfection Technologies Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Transfection Technologies Market: Breakup by Product Type (in %), 2025
  • Figure 4: Global: Transfection Technologies Market: Breakup by Application (in %), 2025
  • Figure 5: Global: Transfection Technologies Market: Breakup by Transfection Method (in %), 2025
  • Figure 6: Global: Transfection Technologies Market: Breakup by Technology (in %), 2025
  • Figure 7: Global: Transfection Technologies Market: Breakup by End-User (in %), 2025
  • Figure 8: Global: Transfection Technologies Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Transfection Technologies (Reagent) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Transfection Technologies (Reagent) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Transfection Technologies (Instrument) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Transfection Technologies (Instrument) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Transfection Technologies (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Transfection Technologies (Therapeutic Delivery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Transfection Technologies (Therapeutic Delivery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Transfection Technologies (Bio-Medical Research) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Transfection Technologies (Bio-Medical Research) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Transfection Technologies (Protein Production) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Transfection Technologies (Protein Production) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Transfection Technologies (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Transfection Technologies (Lipofection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Transfection Technologies (Lipofection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Transfection Technologies (Eletroporation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Transfection Technologies (Eletroporation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Transfection Technologies (Nucleofection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Transfection Technologies (Nucleofection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Transfection Technologies (Cotransfection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Transfection Technologies (Cotransfection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Transfection Technologies (Cationic Lipid Transfection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Transfection Technologies (Cationic Lipid Transfection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Transfection Technologies (In-Vivo Transfection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Transfection Technologies (In-Vivo Transfection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Transfection Technologies (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Transfection Technologies (Physical Transfection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Transfection Technologies (Physical Transfection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Global: Transfection Technologies (Biochemical Based Transfection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Global: Transfection Technologies (Biochemical Based Transfection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Global: Transfection Technologies (Viral-Vector Based Transfection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Global: Transfection Technologies (Viral-Vector Based Transfection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Global: Transfection Technologies (Research Centers and Academic Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Global: Transfection Technologies (Research Centers and Academic Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Global: Transfection Technologies (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Global: Transfection Technologies (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Global: Transfection Technologies (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Global: Transfection Technologies (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Global: Transfection Technologies (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: North America: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: North America: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: United States: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: United States: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Canada: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Canada: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Asia Pacific: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Asia Pacific: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: China: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: China: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Japan: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Japan: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: India: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: India: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: South Korea: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: South Korea: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Australia: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Australia: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Indonesia: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Indonesia: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Others: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Others: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Europe: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Europe: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Germany: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Germany: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: France: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: France: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: United Kingdom: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: United Kingdom: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Italy: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Italy: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Spain: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Spain: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Russia: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Russia: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Others: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 89: Others: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 90: Latin America: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 91: Latin America: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 92: Brazil: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 93: Brazil: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 94: Mexico: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 95: Mexico: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 96: Others: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 97: Others: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 98: Middle East and Africa: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 99: Middle East and Africa: Transfection Technologies Market: Breakup by Country (in %), 2025
  • Figure 100: Middle East and Africa: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 101: Global: Transfection Technologies Industry: SWOT Analysis
  • Figure 102: Global: Transfection Technologies Industry: Value Chain Analysis
  • Figure 103: Global: Transfection Technologies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transfection Technologies Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Transfection Technologies Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Transfection Technologies Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Transfection Technologies Market Forecast: Breakup by Transfection Method (in Million USD), 2026-2034
  • Table 5: Global: Transfection Technologies Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 6: Global: Transfection Technologies Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 7: Global: Transfection Technologies Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 8: Global: Transfection Technologies Market Structure
  • Table 9: Global: Transfection Technologies Market: Key Players